Neuroprotective mechanisms of plant extracts against MPTP induced neurotoxicity: Future applications in Parkinson's disease

Biomedicine and Pharmacotherapy

Volumn 85, Issue , 2017, Pages 635-645

  Abushouk, Abdelrahman Ibrahim ^a,b,c   Negida, Ahmed ^c,d,e   Ahmed, Hussien ^c,d,e   Abdel Daim, Mohamed M ^f  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b NovaMed Medical research Association   (Egypt)

^c Medical Research Group of Egypt   (Egypt)

^d ZAGAZIG UNIVERSITY   (Egypt)

^e ZAGAZIG UNIVERSITY   (Egypt)

^f Suez Canal University   (Egypt)

Author keywords

Mptp; Neuroprotection; Parkinson's disease; Plant extracts

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; PLANT EXTRACT; ANTIOXIDANT; NEUROPROTECTIVE AGENT;

ANTIOXIDANT ACTIVITY; APOPTOSIS; AUTOPHAGY; DRUG MECHANISM; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRECLINICAL STUDY; PRIORITY JOURNAL; REVIEW; ANIMAL; CHEMISTRY; HUMAN; INTOXICATION; PARKINSON DISEASE;

ANIMALS; ANTIOXIDANTS; HUMANS; MPTP POISONING; NEUROPROTECTIVE AGENTS; PARKINSON DISEASE; PLANT EXTRACTS;

EID: 85011971642     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.11.074     Document Type: Review

References (110)

1. [1] De Lau, L.M.L., Breteler, M.M.B., Epidemiology of parkinson's disease. Lancet Neurol. 5 (2006), 525–535.
2. [2] Spillantini, M.G., Schmidt, M.L., VM-Y, Lee, et al. α-Synuclein in lewy bodies. Nature 388 (1997), 839–840.
3. [3] Jellinger, K.A., Pathology of parkinson's disease. Mol. Chem. Neuropathol. 14 (1991), 153–197.
4. [4] Savitt, J.M., Dawson, V.L., Dawson, T.M., Diagnosis and treatment of Parkinson disease: molecules to medicine. J. Clin. Invest. 116 (2006), 1744–1754.
5. [5] Lazzarini, A.M., Myers, R.H., Zimmerman, T.R., et al. A clinical genetic study of Parkinson's disease Evidence for dominant transmission. Neurology, 44, 1994, 499.
6. [6] Maraganore, D.M., De Andrade, M., Lesnick, T.G., et al. High-resolution whole-genome association study of Parkinson disease. Am. J. Hum. Genet. 77 (2005), 685–693.
7. [7] Polymeropoulos, M.H., Lavedan, C., Leroy, E., et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276 (1997), 2045–2047.
8. [8] Weinreb, P.H., Zhen, W., Poon, A.W., et al. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35 (1996), 13709–13715.
9. [9] Spillantini, M.G., Crowther, R.A., Jakes, R., et al. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. 95 (1998), 6469–6473.
10. [10] Winslow, A.R., Chen, C.-W., Corrochano, S., et al. α-Synuclein impairs macroautophagy: implications for Parkinson's disease. J. Cell Biol. 190 (2010), 1023–1037.
11. [11] Mizuno, Y., Mochizuki, H., Hattori, N., Alpha–synuclein, nigral degeneration and parkinsonism. Sci. Basis Treat. Parkinson's Dis., 2005, 87–104.
12. [12] Kitada, T., Asakawa, S., Hattori, N., et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392 (1998), 605–608.
13. [13] Zhang, Y., Gao, J., Chung, K.K.K., Parkin functions as an E2-dependent ubiquitin–protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc. Natl. Acad. Sci. 97 (2000), 13354–13359.
14. [14] Dawson, T.M., Dawson, V.L., The role of parkin in familial and sporadic Parkinson's disease. Mov. Disord. 25 (2010), S32–S39.
15. [15] Pringsheim, T., Jette, N., Frolkis, A., Steeves, T.D.L., The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov. Disord. 29 (2014), 1583–1590.
16. [16] Dawson, T.M., Dawson, V.L., Molecular pathways of neurodegeneration in Parkinson's disease. Science 302 (2003), 819–822.
17. [17] Schmidt, N., Ferger, B., Neurochemical findings in the MPTP model of Parkinson's disease. J. Neural Transm. 108 (2001), 1263–1282.
18. [18] Nakamura, S., Vincent, S.R., Histochemistry of MPTP oxidation in the rat brain: sites of synthesis of the parkinsonism-inducing toxin MPP+. Neurosci. Lett. 65 (1986), 321–325.
19. [19] Langston, J.W., Irwin, I., MPTP: current concepts and controversies. Clin. Neuropharmacol. 9 (1986), 485–507.
20. [20] Gao, H.-M., Liu, B., Zhang, W., Hong, J.-S., Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease. FASEB J. 17 (2003), 1954–1956.
21. [21] Blum, D., Torch, S., Lambeng, N., et al. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog. Neurobiol. 65 (2001), 135–172.
22. [22] Burns, R.S., Chiueh, C.C., Markey, S.P., et al. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. Proc. Natl. Acad. Sci. 80 (1983), 4546–4550.
23. [23] Betarbet, R., Sherer, T.B., Greenamyre, J.T., Animal models of Parkinson's disease. Bioessays 24 (2002), 308–318.
24. [24] Du, T., Li, L., Song, N., et al, Rosmarinic acid antagonized 1-methyl-4-phenylpyridinium (MPP+)-induced neurotoxicity in MES23. 5 dopaminergic cells. Int. J. Toxicol. 29 (2010), 625–633, 10.1177/1091581810383705.
25. +-induced cytotoxicity in human dopaminergic SH-SY5Y cells. J. Ethnopharmacol. 130 (2010), 290–298, 10.1016/j.jep.2010.05.006.
26. [26] Li, F.Q., Cheng, X.X., Liang, X.B., et al. Neurotrophic and neuroprotective effects of tripchlorolide, an extract of Chinese herb Tripterygium wilfordii Hook F, on dopaminergic neurons. Exp. Neurol. 179 (2003), 28–37.
27. [27] Cao, B.Y., Yang, Y.P., Luo, W.F., et al. Paeoniflorin, a potent natural compound, protects PC12 cells from MPP+ and acidic damage via autophagic pathway. J. Ethnopharmacol. 131 (2010), 122–129, 10.1016/j.jep.2010.06.009.
28. [28] Kim, I.S., Choi, D.K., Jung, H.J., Neuroprotective effects of vanillyl alcohol in Gastrodia elata Blume through suppression of oxidative stress and anti-apoptotic activity in toxin-induced dopaminergic MN9D cells. Molecules 16 (2011), 5349–5361, 10.3390/molecules16075349.
29. [29] Zhao, G., Jiang, Z.H., Zheng, X.W., et al. Dopamine transporter inhibitory and antiparkinsonian effect of common flowering quince extract. Pharmacol. Biochem. Behav. 90 (2008), 363–371, 10.1016/j.pbb.2008.03.014.
30. [30] Sheng, G., Pu, X., Lei, L., et al. Tubuloside B from Cistanche salsa rescues the PC12 neuronal cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis and oxidative stress. Planta Med. 68 (2002), 966–970, 10.1055/s-2002-35667.
31. [31] Jia, Z., Zhu, H., Li, Y., Misra, H.P., Cruciferous nutraceutical 3H-1, 2-dithiole-3-thione protects human primary astrocytes against neurocytotoxicity elicited by MPTP, MPP(+), 6-OHDA, HNE and acrolein. Neurochem. Res. 34 (2009), 1924–1934, 10.1007/s11064-009-9978-8.
32. [32] Kim, I.S., Ko, H.M., Koppula, S., et al. Protective effect of Chrysanthemum indicum Linne against 1-methyl-4-phenylpridinium ion and lipopolysaccharide-induced cytotoxicity in cellular model of Parkinson's disease. Food Chem. Toxicol. 49 (2011), 963–973, 10.1016/j.fct.2011.01.002.
33. [33] Kim, I.S., Koppula, S., Park, P.J., et al. Chrysanthemum morifolium Ramat (CM) extract protects human neuroblastoma SH-SY5Y cells against MPP+-induced cytotoxicity. J. Ethnopharmacol. 126 (2009), 447–454, 10.1016/j.jep.2009.09.017.
34. [34] Rojas, P., Garduno, B., Rojas, C., et al. EGb761 blocks MPP+-induced lipid peroxidation in mouse corpus striatum. Neurochem. Res. 26 (2001), 1245–1251.
35. [35] Rojas, P., Serrano-Garcia, N., Medina-Campos, O.N., et al. S-Allylcysteine, a garlic compound, protects against oxidative stress in 1-methyl-4-phenylpyridinium-induced parkinsonism in mice. J. Nutr. Biochem. 22 (2011), 937–944.
36. [36] An, L., Liu, S., Dong, Y., et al. Protective effect of effective part of Acanthopanacis senticosus on damage of PC12 cells induced by MPP+. Zhongguo Zhong Yao Za Zhi 35 (2010), 2021–2026.
37. [37] Jiang, G., Hu, Y., Liu, L., et al. Gastrodin protects against MPP(+)-induced oxidative stress by up regulates heme oxygenase-1 expression through p38 MAPK/Nrf2 pathway in human dopaminergic cells. Neurochem. Int. 75 (2014), 79–88, 10.1016/j.neuint.2014.06.003.
38. [38] Doré, S., Takahashi, M., Ferris, C.D., et al. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc. Natl. Acad. Sci. 96 (1999), 2445–2450.
39. [39] An, L.J., Guan, S., Shi, G.F., et al. Protocatechuic acid from Alpinia oxyphylla against MPP+-induced neurotoxicity in PC12 cells. Food Chem. Toxicol. 44 (2006), 436–443.
40. [40] Huang, J.Z., Chen, Y.Z., Su, M., et al. dl-3-n-Butylphthalide prevents oxidative damage and reduces mitochondrial dysfunction in an MPP(+)-induced cellular model of Parkinson's disease. Neurosci. Lett. 475 (2010), 89–94, 10.1016/j.neulet.2010.03.053.
41. [41] Sheng, G.Q., Zhang, J.R., Pu, X.P., et al. Protective effect of verbascoside on 1-methyl-4-phenylpyridinium ion-induced neurotoxicity in PC12 cells. Eur. J. Pharmacol. 451 (2002), 119–124.
42. [42] Lin, A.M., Wu, L.Y., Hung, K.C., et al, Neuroprotective effects of longan (Dimocarpus longan Lour.) flower water extract on MPP+-induced neurotoxicity in rat brain. J. Agric. Food Chem. 60 (2012), 9188–9194, 10.1021/jf302792t.
43. [43] Ye, Q., Ye, L., Xu, X., et al, Epigallocatechin-3-gallate suppresses 1-methyl-4-phenyl-pyridine-induced oxidative stress in PC12 cells via the SIRT1/PGC-1alpha signaling pathway. BMC Complement. Altern. Med., 12, 2012, 82, 10.1186/1472-6882-12-82.
44. [44] Guo, B., Xu, D., Duan, H., et al. Therapeutic effects of multifunctional tetramethylpyrazine nitrone on models of Parkinson's disease in vitro and in vivo. Biol. Pharm. Bull. 37 (2014), 274–285.
45. [45] Yao, X.L., Wu, W.L., Zheng, M.Y., et al. [Protective effects of Lycium barbarum extract against MPP(+) −induced neurotoxicity in Caenorhabditis elegans and PC12 cells]. Zhong Yao Cai 34 (2011), 1241–1246.
46. [46] Cohen, G.M., Caspases: the executioners of apoptosis. Biochem. J 326 (1997), 1–16.
47. [47] Fang, F., Chen, X.C., Zhu, Y.G., Zhou, Y.C., [Ginsenoside Rg1 may protect SHSY5Y cells from apoptosis induced by MPP+ through JNK way]. Yao Xue Bao 38 (2003), 176–180.
48. [48] Guan, S., Jiang, B., Bao, Y.M., An, L.J., Protocatechuic acid suppresses MPP+ −induced mitochondrial dysfunction and apoptotic cell death in PC12 cells. Food Chem. Toxicol. 44 (2006), 1659–1666, 10.1016/j.fct.2006.05.004.
49. [49] Bo, J., Ming, B.Y., Gang, L.Z., et al. Protection by puerarin against MPP+-induced neurotoxicity in PC12 cells mediated by inhibiting mitochondrial dysfunction and caspase-3-like activation. Neurosci. Res. 53 (2005), 183–188, 10.1016/j.neures.2005.06.014.
50. [50] Deng, Q., Yang, X., Protective effects of Gynostemma pentaphyllum polysaccharides on PC12 cells impaired by MPP(+). Int. J. Biol. Macromol. 69 (2014), 171–175, 10.1016/j.ijbiomac.2014.05.049.
51. [51] D'Amours, D., Germain, M., Orth, K., et al. Proteolysis of poly (ADP-ribose) polymerase by caspase 3: kinetics of cleavage of mono (ADP-ribosyl) ated and DNA-bound substrates. Radiat. Res. 150 (1998), 3–10.
52. [52] Li, Y.Y., Lu, J.H., Li, Q., et al. Pedicularioside A from Buddleia lindleyana inhibits cell death induced by 1-methyl-4-phenylpyridinium ions (MPP + ) in primary cultures of rat mesencephalic neurons. Eur. J. Pharmacol. 579 (2008), 134–140.
53. [53] Pu, X., Song, Z., Li, Y., et al. Acteoside from Cistanche salsa inhibits apoptosis by 1-methyl-4-phenylpyridinium ion in cerebellar granule neurons. Planta Med. 69 (2003), 65–66, 10.1055/s-2003-37029.
54. [54] Tian, X.F., Pu, X.P., Phenylethanoid glycosides from Cistanches salsa inhibit apoptosis induced by 1-methyl-4-phenylpyridinium ion in neurons. J. Ethnopharmacol. 97 (2005), 59–63.
55. [55] Jung, H.W., Jin, G.Z., Kim, S.Y., et al, Neuroprotective effect of methanol extract of Phellodendri Cortex against 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis in PC-12 cells. Cell Biol. Int. 33 (2009), 957–963, 10.1016/j.cellbi.2009.06.006.
56. [56] Bonny, C., Oberson, A., Negri, S., et al. Cell-permeable peptide inhibitors of JNK novel blockers of β-cell death. Diabetes 50 (2001), 77–82.
57. [57] Luo, F.C., Wang, S.D., Li, K., et al. Panaxatriol saponins extracted from Panax notoginseng induces thioredoxin-1 and prevents 1-methyl-4-phenylpyridinium ion-induced neurotoxicity. J. Ethnopharmacol. 127 (2010), 419–423.
58. [58] Saitoh, M., Nishitoh, H., Fujii, M., et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal regulating kinase (ASK) 1. EMBO J. 17 (1998), 2596–2606.
59. [59] Doo, A.R., Kim, S.N., Park, J.Y., et al. Neuroprotective effects of an herbal medicine, Yi-Gan San on MPP+/MPTP-induced cytotoxicity in vitro and in vivo. J. Ethnopharmacol. 131 (2010), 433–442, 10.1016/j.jep.2010.07.008.
60. [60] Singh, M., Murthy, V., Ramassamy, C., Standardized extracts of Bacopa monniera protect against MPP+- and paraquat-induced toxicity by modulating mitochondrial activities, proteasomal functions, and redox pathways. Toxicol. Sci. 125 (2012), 219–232, 10.1093/toxsci/kfr255.
61. [61] Franke, T.F., Hornik, C.P., Segev, L., et al. PI3K/Akt and apoptosis: size matters. Oncogene 22 (2003), 8983–8998.
62. [62] Volkmann, N., Marassi, F.M., Newmeyer, D.D., Hanein, D., The rheostat in the membrane: BCL-2 family proteins and apoptosis. Cell Death Differ. 21 (2014), 206–215.
63. [63] Liu, W., Kong, S., Xie, Q., et al. Protective effects of apigenin against 1-methyl-4-phenylpyridinium ioninduced neurotoxicity in PC12 cells. Int. J. Mol. Med. 35 (2015), 739–746.
64. [64] Bae, N., Chung, S., Kim, H.J., et al. Neuroprotective effect of modified Chungsimyeolda-tang, a traditional Korean herbal formula, via autophagy induction in models of Parkinson's disease. J. Ethnopharmacol. 159 (2015), 93–101.
65. [65] Liu, K., Huang, J., Chen, R., et al. Protection against neurotoxicity by an autophagic mechanism. Braz. J. Med. Biol. Res. 45 (2012), 401–407.
66. [66] Herraiz, T., Evaluation of the oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to toxic pyridinium cations by monoamine oxidase (MAO) enzymes and its use to search for new MAO inhibitors and protective agents. J. Enzyme Inhib. Med. Chem. 27 (2012), 810–817.
67. [67] Rojas, P., Rojas, C., Ebadi, M., et al. EGb761 pretreatment reduces monoamine oxidase activity in mouse corpus striatum during 1-methyl-4-phenylpyridinium neurotoxicity. Neurochem. Res. 29 (2004), 1417–1423.
68. [68] Zhao, G., Zheng, X.W., Qin, G.W., et al. In vitro dopaminergic neuroprotective and in vivo antiparkinsonian-like effects of Delta 3,2-hydroxybakuchiol isolated from Psoralea corylifolia (L.). Cell. Mol. Life Sci. 66 (2009), 1617–1629, 10.1007/s00018-009-9030-9.
69. [69] Pan, T., Fei, J., Zhou, X., et al. Effects of green tea polyphenols on dopamine uptake and on MPP+ −induced dopamine neuron injury. Life Sci. 72 (2003), 1073–1083.
70. [70] Baldereschi, M., Di Carlo, A., Rocca, W.A., et al. Parkinson's disease and parkinsonism in a longitudinal study Two-fold higher incidence in men. Neurology 55 (2000), 1358–1363.
71. [71] Van Den Eeden, S.K., Tanner, C.M., Bernstein, A.L., et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am. J. Epidemiol. 157 (2003), 1015–1022.
72. [72] Benedetti, M.D., Maraganore, D.M., Bower, J.H., et al. Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case control study. Mov. Disord. 16 (2001), 830–837.
73. [73] Quesada, A., Micevych, P.E., Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions. J. Neurosci. Res. 75 (2004), 107–116.
74. [74] Gelinas, S., Martinoli, M.G., Neuroprotective effect of estradiol and phytoestrogens on MPP+-induced cytotoxicity in neuronal PC12 cells. J. Neurosci. Res. 70 (2002), 90–96, 10.1002/jnr.10315.
75. [75] Lynch, M.A., The multifaceted profile of activated microglia. Mol. Neurobiol. 40 (2009), 139–156.
76. [76] Filipov, N.M., Seegal, R.F., Lawrence, D.A., Manganese potentiates in vitro production of proinflammatory cytokines and nitric oxide by microglia through a nuclear factor kappa B—dependent mechanism. Toxicol. Sci. 84 (2005), 139–148.
77. [77] Hebron, M.L., Lonskaya, I., Moussa, C.E.-H., Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of α-synuclein in Parkinson's disease models. Hum. Mol. Genet. 22 (2013), 3315–3328.
78. [78] Sarkar, S., Chigurupati, S., Raymick, J., et al. Neuroprotective effect of the chemical chaperone, trehalose in a chronic MPTP-induced Parkinson's disease mouse model. Neurotoxicology 44 (2014), 250–262.
79. [79] Da Rocha Lindner, G., Santos, D.B., Colle, D., et al. Improved neuroprotective effects of resveratrol-loaded polysorbate 80-coated poly (lactide) nanoparticles in MPTP-induced Parkinsonism. Nanomedicine 10 (2015), 1127–1138.
80. [80] Lofrumento, D.D., Nicolardi, G., Cianciulli, A., et al. Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson's-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses. Innate immun. 20 (2014), 249–260.
81. [81] Prema, A., Janakiraman, U., Manivasagam, T., Thenmozhi, A.J., Neuroprotective effect of lycopene against MPTP induced experimental Parkinson's disease in mice. Neurosci. Lett. 599 (2015), 12–19.
82. [82] Ramagiri, S., Taliyan, R., Neuroprotective effect of hydroxy safflor yellow A against cerebral ischemia-reperfusion injury in rats: putative role of mPTP. J. Basic Clin. Physiol. Pharmacol. 27 (2016), 1–8.
83. [83] Sridharan, S., Mohankumar, K., Jeepipalli, S.P.K., et al. Neuroprotective effect of Valeriana wallichii rhizome extract against the neurotoxin MPTP in C57BL/6 mice. Neurotoxicology 51 (2015), 172–183.
84. [84] Bi, Y., Qu, P.-C., Wang, Q.-S., et al. Neuroprotective effects of alkaloids from Piper longum in a MPTP-induced mouse model of Parkinson's disease. Pharm. Biol. 53 (2015), 1516–1524.
85. [85] Zhou, T., Zu, G., Wang, X., et al. Immunomodulatory and neuroprotective effects of ginsenoside Rg1 in the MPTP (1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine)-induced mouse model of Parkinson's disease. Int. Immunopharmacol. 29 (2015), 334–343.
86. [86] Friedemann, T., Ying, Y., Wang, W., et al. Neuroprotective effect of coptis chinensis in MPP+ and MPTP-induced parkinson's disease models. Am. J. Chin. Med. 44 (2016), 907–925.
87. [87] Wang, Y.-Q., Wang, M.-Y., Fu, X.-R., et al. Neuroprotective effects of ginkgetin against neuroinjury in Parkinson's disease model induced by MPTP via chelating iron. Free Radic. Res. 49 (2015), 1069–1080.
88. [88] Moldzio, R., Pacher, T., Krewenka, C., et al. Effects of cannabinoids Delta(9)-tetrahydrocannabinol, Delta(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures. Phytomedicine 19 (2012), 819–824, 10.1016/j.phymed.2012.04.002.
89. [89] Guo, H., Shi, F., Li, M., et al. Neuroprotective effects of Eucommia ulmoides Oliv. and its bioactive constituent work via ameliorating the ubiquitin-proteasome system. BMC Complement. Altern. Med., 15(151), 2015, 10.1186/s12906-015-0675-7.
90. [90] Bae, N., Ahn, T., Chung, S., et al. The neuroprotective effect of modified Yeoldahanso-tang via autophagy enhancement in models of Parkinson's disease. J. Ethnopharmacol. 134 (2011), 313–322.
91. [91] Xu, J., Yang, B., Guo, Y., et al. Neuroprotective bakkenolides from the roots of Valeriana jatamansi. Fitoterapia 82 (2011), 849–853, 10.1016/j.fitote.2011.04.012.
92. [92] Rojas, P., Montes, S., Serrano-Garcia, N., Rojas-Castaneda, J., Effect of EGb761 supplementation on the content of copper in mouse brain in an animal model of Parkinson's disease. Nutrition 25 (2009), 482–485.
93. [93] Patil, S.P., Jain, P.D., Sancheti, J.S., et al. Neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice. Neuropharmacology 86 (2014), 192–202.
94. [94] Meenakshi, S., Umayaparvathi, S., Saravanan, R., et al. Neuroprotective effect of fucoidan from Turbinaria decurrens in MPTP intoxicated Parkinsonic mice. Int. J. Biol. Macromol. 86 (2016), 425–433.
95. [95] Yadav, S.K., Prakash, J., Chouhan, S., et al. Comparison of the neuroprotective potential of Mucuna pruriens seed extract with estrogen in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced PD mice model. Neurochem. Int. 65 (2014), 1–13.
96. [96] Pérez-H, J., Carrillo-S, C., García, E., et al. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease. Toxicology 319 (2014), 38–43.
97. [97] Shu, D., He, J., Chen, J., [Neuroprotective effects and mechanisms of Chuanxiong Chatiao pulvis against MPTP-induced dopaminergic neurotoxicity in mice model of Parkinson's disease]. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China J. Chin. Materia Medica 34 (2009), 2494–2497.
98. [98] Chen, Y., Zhang, Y., Li, L., Hölscher, C., Neuroprotective effects of geniposide in the MPTP mouse model of Parkinson's disease. Eur. J. Pharmacol. 768 (2015), 21–27.
99. [99] Liu, J., Gao, J., Tu, S., et al. Neuroprotective effects of Jitai tablet, a traditional Chinese medicine, on the MPTP-induced acute model of Parkinson's disease: involvement of the dopamine system. Evid.-Based Complement. Altern. Med., 2014, 2014 (Article ID 542383, 9 pages).
100. [100] Guo, P., Li, Y., Xu, J., et al. neo-Clerodane diterpenes from Ajuga ciliata Bunge and their neuroprotective activities. Fitoterapia 82 (2011), 1123–1127, 10.1016/j.fitote.2011.07.010.
101. [101] Xu, J., Li, Y., Guo, Y., et al. Isolation, structural elucidation, and neuroprotective effects of iridoids from Valeriana jatamansi. Biosci. Biotechnol. Biochem. 76 (2012), 1401–1403, 10.1271/bbb.120097.
102. [102] Yu, Z.Y., Ruan, H.L., Zhu, X.N., et al. [Isolation and identification of Suavissimoside R1 from roots of Rubus parvifollus used for protecting dopaminergic neurons against MPP+ toxicity]. Zhong Yao Cai 31 (2008), 554–557.
103. [103] Beal, M.F., Oakes, D., Shoulson, I., et al. A randomized clinical trial of high-dosage coenzyme q10 in early Parkinson disease: no evidence of benefit. JAMA Neurol. 71 (2014), 543–552, 10.1001/jamaneurol.2014.131.
104. [104] Negida, A., Menshawy, A., El Ashal, G., et al. Coenzyme Q10 for patients with parkinson's disease: a systematic review and meta-analysis, CNS &. Neurol. Disord. Drug Targ. 15 (2016), 45–53.
105. [105] (1996) Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Parkinson Study Group. Annals of neurology 39:37–45. 10.1002/ana.410390107.
106. [106] Olanow, C.W., Schapira, A.H.V., LeWitt, P.A., et al. TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol. 5 (2006), 1013–1020, 10.1016/S1474-4422(06)70602-0.
107. [107] Parkinson Study Group, Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease. Neurology 69 (2007), 1480–1490, 10.1212/01.wnl.0000277648.63931.c0.
108. [108] Parkinson Study Group, Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. N. Engl. J. Med. 328 (1993), 176–183, 10.1056/NEJM199301213280305.
109. [109] Snow, B.J., Rolfe, F.L., Lockhart, M.M., et al. A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease, Movement disorders. Off. J. Mov. Disord. Soc. 25 (2010), 1670–1674, 10.1002/mds.23148.
110. [110] Abushouk, A.I., Duc, N.M., Curing neurophobia in medical schools: evidence-based strategies. Med. Educ. Online, 21, 2016, 32476.